Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently

Published:2022-10-14 Issue:4 Volume:66 Page:754-770
ISSN:1674-7305
Container-title:Science China Life Sciences
language:en
Short-container-title:Sci. China Life Sci.

Author:

Chen Zhaoqi,Liu Yan,Chen Nianci,Xing Haiyan,Tian Zheng,Tang Kejing,Rao Qing,Xu Yingxi,Wang Ying,Wang Min,Wang Jianxiang

Publisher

Springer Science and Business Media LLC

Subject

General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s11427-022-2173-9.pdf

Reference49 articles.

1. Ajina, A., and Maher, J. (2018). Strategies to address chimeric antigen receptor tonic signaling. Mol Cancer Ther 17, 1795–1815.

2. An, N., Tao, Z., Li, S., Xing, H., Tang, K., Tian, Z., Rao, Q., Wang, M., and Wang, J. (2016). Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells. Oncotarget 7, 10638–10649.

3. Andrews, L.P., Marciscano, A.E., Drake, C.G., and Vignali, D.A.A. (2017). LAG3 (CD223) as a cancer immunotherapy target. Immunol Rev 276, 80–96.

4. Bar, L., Nguyen, C., Galibert, M., Santos-Schneider, F., Aldrian, G., Dejeu, J., Lartia, R., Coche-Guérente, L., Molina, F., and Boturyn, D. (2021). Determination of the Rituximab Binding Site to the CD20 Epitope Using SPOT Synthesis and Surface Plasmon Resonance Analyses. Anal Chem, https://doi.org/10.1021/acs.analchem.1c00960.

5. Baumann, S., Krueger, A., Kirchhoff, S., and Krammer, P.H. (2002). Regulation of T cell apoptosis during the immune response. Curr Mol Med 2, 257–272.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer;British Journal of Pharmacology;2024-08-11

2. Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy;Experimental Hematology & Oncology;2023-07-24

3. Targeted CD7 CAR T-cells for treatment of T-Lymphocyte leukemia and lymphoma and acute myeloid leukemia: recent advances;Frontiers in Immunology;2023-05-05

4. Progress in immunotherapy;Science China Life Sciences;2023-03-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3